Highest-materiality recent filing
Doximity Q4 GAAP net income sinks 69%; guides ~4% FY2027 revenue growth; new CFO and President
FY2026 revenue $644.9M (+13% YoY); GAAP net income $196.1M (down 12% YoY, margin 30.4%).
Doximity CFO Anna Bryson resigns; interim CFO continues; guidance reaffirmed
Anna Bryson's resignation as CFO accepted April 13, 2026, following medical leave since Feb 5, 2026.
Doximity Q3 revenue up 10% to $185M, guides Q4 $143-144M, authorizes $500M buyback
Revenue $185.1M (+10% YoY); net income $61.6M (33% margin) vs $75.2M (45% margin) YoY.
Doximity agrees to $31M settlement to resolve securities class action
Settlement payment of $31 million fully funded by insurance proceeds; no admission of liability.
Doximity reports Q2 revenue $168.5M (+23% YoY), adjusted EBITDA $100.8M; raises FY guidance
Revenue $168.5M vs $136.8M YoY, up 23%; non-GAAP net income $90.0M (53.4% margin).
Jeff Tangney and Kira Wampler elected as Class I directors to serve until 2028 annual meeting.
Doximity GC Jennifer Chaloemtiarana to step down; John Vaughan named replacement
Jennifer Chaloemtiarana steps down as General Counsel, Corporate Secretary, and Chief Compliance Officer effective August 29, 2025.
Doximity Q1 revenue $145.9M (+15%), adj. EBITDA $79.8M (+21%), raises FY guidance
Revenue $145.9M (+15% YoY); net income $53.3M (36.5% margin); non-GAAP EPS $0.36.
Doximity co-founder Dr. Nathan Gross steps down as CSO, stays as advisor
Dr. Gross transitions from Chief Strategy Officer to advisor effective June 16, 2025.
On June 10, 2025, Dr. Nathan Gross notified Doximity, Inc. (the “Company”) that he will step down from his role as Chief Strategy Officer to become an advisor to the Company, effective June 16, 2025.
Max materiality 0.85 · Median 0.65 · Most common event earnings